EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Artificial intelligence for detection of prostate cancer in biopsies during active surveillance

Ida Arvidsson, Edvard Svanemur, Felicia Marginean, Athanasios Simoulis iD, Niels Christian Overgaard, Kalle Åström, Anders Heyden, Agnieszka Krzyzanowska iD, Anders Bjartell iD

BJU International · 2024

DOI: 10.1111/bju.16456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Ida Arvidsson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mathematical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Artificial Intelligence, Algorithms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Swedish Cancer Society, Swedish Research Council, The Research Funds at Skåne University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate a cancer detecting artificial intelligence (AI) algorithm on serial biopsies in patients with prostate cancer on active surveillance (AS). Patients and methods A total of 180 patients in the Prostate Cancer Research International Active Surveillance (PRIAS) cohort were prospectively monitored using pre‐defined criteria. Diagnostic and re‐biopsy slides from 2011 to 2020 ( n = 4744) were scanned and analysed by an in‐house AI‐based cancer detection algorithm. The algorithm was analysed for sensitivity, specificity, and for accuracy to predict need for active treatment. Prognostic properties of cancer size, prostate‐specific antigen (PSA) level and PSA density at diagnosis were evaluated.

Results

The sensitivity and specificity of the AI algorithm was 0.96 and 0.73, respectively, for correct detection of cancer areas. Original pathology report diagnosis was used as the reference method. The area of cancer estimated by the pathologists correlated highly with the AI detected cancer size ( r = 0.83). By using the AI algorithm, 63% of the slides would not need to be read by a pathologist as they were classed as benign, at the risk of missing 0.55% slides containing cancer. Biopsy cancer content and PSA density at diagnosis were found to be prognostic of whether the patient stayed on AS or was discontinued for active treatment.

Conclusion

The AI‐based biopsy cancer detection algorithm could be used to reduce the pathologists’ workload in an AS cohort. The detected cancer amount correlated well with the cancer length measured by the pathologist and the algorithm performed well in finding even small areas of cancer. To our knowledge, this is the first report on an AI‐based algorithm in digital pathology used to detect cancer in a cohort of patients on AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsArtificial IntelligenceAlgorithmsHumansMaleAgedMiddle AgedBiopsyWatchful WaitingProspective StudiesProstate-Specific AntigenSensitivity and Specificity

Stichwörter der Autor:innen

PRIASactive surveillanceartificial intelligencedeep learningprostate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Centre for Mathematical Sciences, Lund University, Lund, Sweden.
  • Department of Urology, Vrinnevi Hospital, Norrköping, Sweden.
  • Division of Urological Cancers, Department of Translational Medicine, Lund University, Lund, Sweden.
  • Department of Pathology and Molecular Diagnostics, Skåne University Hospital, Malmö, Sweden.
  • Department of Urology, Skåne University Hospital, Malmö, Sweden.

ORCID-Profile: Athanasios Simoulis, Agnieszka Krzyzanowska, Anders Bjartell

Förderung

  • The Swedish Cancer Society
  • Swedish Research Council
  • The Research Funds at Skåne University Hospital
  • The Governmental Funding (ALF) through The Faculty of Medicine, Lund University
  • The Swedish Prostate Cancer Federation
  • Vetenskapsrådet

Zitieren

APA

Arvidsson, I., Svanemur, E., Marginean, F., Simoulis, A., Overgaard, N. C., Åström, K., Heyden, A., Krzyzanowska, A., & Bjartell, A. (2024). Artificial intelligence for detection of prostate cancer in biopsies during active surveillance. BJU International. https://doi.org/10.1111/bju.16456

Vancouver

Arvidsson I, Svanemur E, Marginean F, Simoulis A, Overgaard NC, Åström K, et al. Artificial intelligence for detection of prostate cancer in biopsies during active surveillance. BJU International. 2024. doi:10.1111/bju.16456

BibTeX
@article{Arvidsson2024,
  author = {Arvidsson, Ida and Svanemur, Edvard and Marginean, Felicia and Simoulis, Athanasios and Overgaard, Niels Christian and Åström, Kalle and Heyden, Anders and Krzyzanowska, Agnieszka and Bjartell, Anders},
  title = {Artificial intelligence for detection of prostate cancer in biopsies during active surveillance},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16456}
}
Kostenlos starten →